AstraZeneca's $578M Vaccine Plant In Doubt As UK Government Cuts Funding

Name: AstraZeneca's $578M Vaccine Plant In Doubt As UK Government Cuts Funding
Uploaded: 2024-08-14T18:03:29+00:00
Duration: 49 s
Channel: Benzinga
Description: AstraZeneca established its vaccines unit after collaborating with the University of Oxford to develop a COVID-19 vaccine. The existing site, currently used for producing the nasal flu vaccine FluMist, is set to be upgraded under the new investment.

Benzinga

AstraZeneca established its vaccines unit after collaborating with the University of Oxford to develop a COVID-19 vaccine. The existing site, currently used for producing the nasal flu vaccine FluMist, is set to be upgraded under the new investment.

Category

Transcript

Comments

Recommended